Cerebellar Glioblastoma Characteristics and Prognostic Factors

Cerebellar glioblastoma is an uncommon subset of grade 4 gliomas arising in the infratentorial compartment, representing fewer than 1 per cent of all glioblastomas. Patients often present with symptoms of raised intracranial pressure, ataxia and cerebellar dysfunction. Radiologically, lesions typically show heterogeneous enhancement and may infiltrate adjacent brainstem structures. Histological examination reveals the hallmark features of necrosis and microvascular proliferation, yet molecular profiling has exposed a spectrum of entities beneath the umbrella of cerebellar glioblastoma. Recent studies have delineated distinct methylation classes including high-grade astrocytoma with piloid features, H3 K27M-mutant diffuse midline glioma and IDH-wildtype glioblastoma, each carrying different therapeutic susceptibilities. Standard treatment consists of maximal safe surgical resection followed by radiotherapy and temozolomide chemotherapy, although the extent of resection and delivery of adjuvant radiotherapy remain key determinants of outcome. Established prognostic factors encompass patient age, performance status, histological grade, molecular markers and completeness of resection. While earlier work suggested a poorer prognosis for cerebellar versus supratentorial glioblastoma, more recent matched-pair analyses indicate comparable overall and progression-free survival when key variables are balanced. Ongoing efforts to integrate molecular subclassification into clinical decision-making promise to refine risk stratification and individualise therapeutic approaches for this rare and heterogeneous tumour.

Research from Nature Portfolio

Large-scale population data have been harnessed to develop predictive nomograms for patients with cerebellar glioma, identifying age at diagnosis, WHO grade, histological subtype and extent of resection as the most influential variables for overall survival. This tool demonstrated high discriminatory power in both training and validation cohorts, offering clinicians a straightforward graphical model to guide prognosis and management. In a complementary survival analysis focused on glioblastomas of the cerebellopontine angle, hydrocephalus at presentation and omission of adjuvant radiotherapy emerged as independent predictors of shortened survival, emphasising the importance of early cerebrospinal fluid diversion and comprehensive postoperative therapy for infratentorial lesions.

Cerebellar Glioblastoma Characteristics and Prognostic Factors publication trend

The graph below shows the total number of articles in cerebellar glioblastoma characteristics and prognostic factors across all publications each year (not limited to Nature Index journals).

Technical terms

Nomogram: A graphical tool that integrates multiple prognostic variables to predict individual patient outcomes.

Methylation class: A subgroup defined by DNA methylation profiling, reflecting distinct tumour biology and clinical behaviour.

H3 K27M mutation: A lysine-to-methionine substitution in histone H3 that characterises a subset of diffuse midline gliomas with specific therapeutic considerations.

Extent of resection: The proportion of tumour surgically removed, ranging from biopsy to gross total resection, which correlates with survival outcomes.

Overall survival (OS): The interval from diagnosis or treatment initiation to death from any cause, used to assess treatment efficacy.

Progression-free survival (PFS): The duration during which a patient’s disease does not worsen, serving as an indicator of treatment impact on tumour control.

References

1. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities. Acta Neuropathologica Communications (2019).
2. Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature. Cancers (2022).
3. Cerebellar glioblastoma in adults: a comparative single-center matched pair analysis and systematic review of the literature. Journal of Cancer Research and Clinical Oncology (2024).
4. Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database. Scientific Reports (2021).
5. An integrative survival analysis and a systematic review of the cerebellopontine angle glioblastomas. Scientific Reports (2023).